TEVA Pharmaceuticals submits ANDA219413 for FDA review
TEVA Pharmaceuticals has submitted ANDA219413 to the FDA with a standard review priority.
Company
Pharmaceutical intelligence for TEVA PHARMACEUTICALS, INC with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.